Deutsche Bank
WX

Deutsche Bank’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Deutsche Bank’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-40,795
Closed -$1.76M – 5571
2015
Q3 		$1.76M Sell
40,795
-85,947
-68% -$3.63M ﹤0.01% 2574
2015
Q2 		$5.35M Sell
126,742
-13,964
-10% -$589K ﹤0.01% 1757
2015
Q1 		$5.46M Buy
140,706
+36,980
+36% +$1.42M ﹤0.01% 1719
2014
Q4 		$3.49M Sell
103,726
-33,655
-24% -$1.19M ﹤0.01% 2241
2014
Q3 		$4.81M Sell
137,381
-42,016
-23% -$1.44M ﹤0.01% 1866
2014
Q2 		$5.89M Buy
179,397
+42,174
+31% +$1.44M ﹤0.01% 1710
2014
Q1 		$5.05M Buy
137,223
+31,089
+29% +$1.14M ﹤0.01% 1816
2013
Q4 		$4.07M Buy
106,134
+24,644
+30% +$778K ﹤0.01% 1888
2013
Q3 		$2.23M Sell
81,490
-6,334
-7% -$150K ﹤0.01% 2412
2013
Q2 		$1.84M Buy
+87,824
New +$1.71M ﹤0.01% 2271

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Deutsche Bank's WX Position: Q4 2015 in Review

Deutsche Bank sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 40,795 shares — an estimated $1.76M sold.

Deutsche Bank first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $5.89M in Q2 2014. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Deutsche Bank reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Deutsche Bank sold 40,795 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $1.76M.
  • Deutsche Bank first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
  • Deutsche Bank's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $5.89M in Q2 2014.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Deutsche Bank's 13F filing for Q4 2015, filed 16 Feb 2016.